A population-based observational study of men and women aged 35-69 years in the Hunter Region of New South Wales, Australia, was conducted to assess the impact of risk-factor modification and increased drug therapy on the trends in major coronary events and case fatality.
From 1985 to 1993, there were 3006 coronary deaths and 6450 nonfatal major coronary events.
Rates of death and nonfatal myocardial infarction declined, but there was an increase in hospital admissions for prolonged chest pain.
Reductions in cigarette smoking, diastolic blood pressure, total cholesterol, and increased use of aspirin can fully explain the 3.3% (95% confidence interval [CI] 2.4,4.2) average annual reduction in rates of major coronary events for men and the 4.1% (95% CI 2.7,5.5) reduction for women.
In contrast, increased use of aspirin, beta-blockers, fibrinolytic therapy, and angiotensin-converting enzyme inhibitors explain less than half of the 8.9% (95% CI 5.9,11.8) and 6.9% (95% CI 2.7,10.9) average annual reduction in case fatality in hospital for men and women, respectively.
These trends suggest a decline in severity of coronary heart disease consistent with reductions in risk-factor levels and improved acute medical treatment.
Mots-clés Pascal : Infarctus, Myocarde, Cardiopathie coronaire, Facteur risque, Soin, Soin santé primaire, Milieu hospitalier, Prévention, Epidémiologie, Evolution, Homme, Australie, Océanie, Appareil circulatoire pathologie, Myocarde pathologie, Soins médicaux
Mots-clés Pascal anglais : Infarct, Myocardium, Coronary heart disease, Risk factor, Care, Primary health care, Hospital environment, Prevention, Epidemiology, Evolution, Human, Australia, Oceania, Cardiovascular disease, Myocardial disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0467379
Code Inist : 002B12A03. Création : 22/03/2000.